Oncology
1 drug is in development for CRC (Colorectal Cancer).
- Companies
- 1
- Clinical trials
- 8
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the CRC (Colorectal Cancer) pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| decoy20 | Indaptus Therapeutics, Inc. (INDP) |
About this indication
CRC (Colorectal Cancer) context
Oncology·MeSH: Colorectal Neoplasms (D015179)
Narrower concept of MeSH descriptor Colorectal Neoplasms
Prevalence
135.0 / 100K
Incidence
36.0 / 100K/yr
Frequently asked questions
How many drugs are in development for CRC (Colorectal Cancer)?
BioSniper tracks 1 drug in development for CRC (Colorectal Cancer) across 1 company.
How many clinical trials target CRC (Colorectal Cancer)?
There are 8 clinical trials targeting CRC (Colorectal Cancer) tracked by BioSniper.
What is the prevalence of CRC (Colorectal Cancer)?
The estimated prevalence of CRC (Colorectal Cancer) is approximately 135.0 per 100,000 population.